Phenylpropanolamine Polistirex
Generic Name: phenylpropanolamine polistirex
Manufactured by UCB INC. Dosage form: SUSPENSION, EXTENDED RELEASE. Route: ORAL. Active ingredients: CHLORPHENIRAMINE POLISTIREX (EQ 4MG MALEATE/5ML); PHENYLPROPANOLAMINE POLISTIREX (EQ 37.5MG HCL/5ML). Application: NDA018050.
Overview
Manufactured by UCB INC. Dosage form: SUSPENSION, EXTENDED RELEASE. Route: ORAL. Active ingredients: CHLORPHENIRAMINE POLISTIREX (EQ 4MG MALEATE/5ML); PHENYLPROPANOLAMINE POLISTIREX (EQ 37.5MG HCL/5ML). Application: NDA018050.
Dosage
Available as suspension, extended release for oral use.
Related Medications
Mepsevii
mepsevii
Dosage form: INJECTION. Active ingredients: VESTRONIDASE ALFA (2 mg/mL). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Ragweed, Giant Ambrosia Trifida
ragweed, giant ambrosia trifida
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: AMBROSIA TRIFIDA POLLEN (.05 g/mL). Category: BLA.
Montelukast Sodium
montelukast sodium
Leukotriene Receptor Antagonist [EPC]
11 DESCRIPTION Montelukast sodium, USP the active ingredient in montelukast sodium chewable tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium, USP is described chemically as 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl) ethenyl] phenyl]-3-[2- (1-hydroxy-1-methylethyl) phenyl] propyl] thio] methyl] cyclopropane acetic acid, sodium salt.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.